Mara Macdonald is an Investment Manager at Brandon Capital. She currently serves on the board of Entact Bio and Kimaritec.
Before joining Brandon Capital, Mara was co-founder and COO of CytoVale, a San Francisco based startup developing a new diagnostic modality. Prior to this, Mara worked as a key member of an interdisciplinary team at Third Rock Ventures where she was focused on launching transformative life science companies, including Nurix and Decibel. Earlier, she worked with ClearView Healthcare Partners where she spearheaded commercial strategies and M&A due diligence on behalf of top 10 and speciality pharmaceutical clients across diverse therapeutic areas.
Mara has a PhD from the Harvard MIT Division of Health Sciences and Technology in Medical and Chemical Engineering where she was an NSF Graduate Research Fellow and Fulbright Scholar. She holds a Bachelor of Science in Chemical Engineering from University of Colorado Boulder and is a Graduate of the Australian Institute of Company Directors (GAICD).